VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+9.34%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$612M
AUM Growth
+$115M
(+23%)
Cap. Flow
+$92.1M
Cap. Flow
% of AUM
15.06%
Top 10 Holdings %
Top 10 Hldgs %
8.98%
Holding
532
New
97
Increased
238
Reduced
88
Closed
80
Top Buys
| 1 |
Telecom Argentina
TEO
|
$2.3M |
| 2 |
Methanex
MEOH
|
$1.47M |
| 3 |
The GEO Group
GEO
|
$1.43M |
| 4 |
EQM
EQM Midstream Partners, LP
EQM
|
$1.42M |
| 5 |
Vale
VALE
|
$1.35M |
Top Sells
| 1 |
Oxford Square Capital
OXSQ
|
$2.69M |
| 2 |
MPLX
MPLX
|
$1.51M |
| 3 |
MDCO
Medicines Co
MDCO
|
$982K |
| 4 |
Gladstone Investment Corp
GAIN
|
$839K |
| 5 |
CELG
Celgene Corp
CELG
|
$712K |
Sector Composition
| 1 | Financials | 20.46% |
| 2 | Real Estate | 16.88% |
| 3 | Energy | 14.34% |
| 4 | Healthcare | 10.85% |
| 5 | Materials | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Axsome Therapeutics
AXSM
$6.25B
| $910K | 0.15% |
8,801
-2,275
| -21% | -$235K |
|
152
Theravance Biopharma
TBPH
$703M
| $756K | 0.12% |
29,216
-14,226
| -33% | -$368K |
|
|
MNTA
153
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $753K | 0.12% |
38,162
-19,687
| -34% | -$388K |
|
154
Karyopharm Therapeutics
KPTI
$57.2M
| $730K | 0.12% |
2,540
-410
| -14% | -$118K |
|
|
ICPT
155
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $693K | 0.11% |
5,591
-3,120
| -36% | -$387K |
|
|
AIMT
156
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $682K | 0.11% |
20,386
+7,752
| +61% | +$259K |
|
157
Regeneron Pharmaceuticals
REGN
$60.8B
| $677K | 0.11% |
1,803
-468
| -21% | -$176K |
|
|
STML
158
DELISTED
Stemline Therapeutics, Inc.
STML
| $675K | 0.11% |
63,484
+14,578
| +30% | +$155K |
|
159
BioMarin Pharmaceuticals
BMRN
$11.1B
| $673K | 0.11% |
7,956
-610
| -7% | -$51.6K |
|
160
Omeros
OMER
$284M
| $671K | 0.11% |
47,622
+4,838
| +11% | +$68.2K |
|
|
XLRN
161
DELISTED
Acceleron Pharma Inc.
XLRN
| $671K | 0.11% |
12,648
+5,927
| +88% | +$314K |
|
162
Ironwood Pharmaceuticals
IRWD
$188M
| $664K | 0.11% |
49,885
-16,931
| -25% | -$225K |
|
|
GBT
163
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $660K | 0.11% |
8,303
+3,626
| +78% | +$288K |
|
|
ALXN
164
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $660K | 0.11% |
6,101
+38
| +0.6% | +$4.11K |
|
165
Biogen
BIIB
$20.6B
| $659K | 0.11% |
2,222
-948
| -30% | -$281K |
|
166
Amicus Therapeutics
FOLD
$2.46B
| $659K | 0.11% |
67,661
+6,608
| +11% | +$64.4K |
|
167
Insmed
INSM
$30.7B
| $657K | 0.11% |
27,494
+16,885
| +159% | +$403K |
|
168
Agios Pharmaceuticals
AGIO
$2.09B
| $652K | 0.11% |
13,663
-755
| -5% | -$36K |
|
169
Amgen
AMGN
$153B
| $651K | 0.11% |
2,699
-1,240
| -31% | -$299K |
|
170
Nektar Therapeutics
NKTR
$764M
| $648K | 0.11% |
2,000
+617
| +45% | +$200K |
|
|
SGEN
171
DELISTED
Seagen Inc. Common Stock
SGEN
| $640K | 0.1% |
5,604
-4,516
| -45% | -$516K |
|
172
Ultragenyx Pharmaceutical
RARE
$3.07B
| $638K | 0.1% |
14,936
+2,818
| +23% | +$120K |
|
173
Vertex Pharmaceuticals
VRTX
$102B
| $637K | 0.1% |
2,908
-1,160
| -29% | -$254K |
|
174
PTC Therapeutics
PTCT
$4.55B
| $635K | 0.1% |
13,226
+6,918
| +110% | +$332K |
|
|
SAGE
175
DELISTED
Sage Therapeutics
SAGE
| $632K | 0.1% |
8,753
+4,769
| +120% | +$344K |
|